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HYALURONAN RAFTS ON AIRWAY EPITHELIAL CELLS
AMINA M. ABBADI

ABSTRACT
Many cells, including murine airway epithelial cells, respond to a variety of
inflammatory stimuli by synthesizing leukocyte-adhesive hyaluronan cables that
remain attached to their cell surfaces. This study shows that air-liquid interface
cultures of murine airway epithelial cells (AECs) also actively synthesize and release a
majority of their HA onto their ciliated apical surfaces to form a heavy chainhyaluronan (HC-HA) matrix in the absence of inflammatory stimuli. These matrices
do not resemble the rope-like HA cables, but occur in distinct sheets, or rafts, that can
capture and embed leukocytes from cell suspensions. The HC-HA modification
involves the transfer of heavy chains from the inter-α-inhibitor (IαI) proteoglycan,
which has 2 heavy chains (HC1 and HC2) on its chondroitin sulfate (CS) chain. The
tranesterification transfer of HCs from CS to HA is mediated by tumor-necrosisfactor-induced-gene 6 (TSG-6), which is upregulated in inflammatory reactions.
Because the AEC cultures do not have TSG-6 nor serum, which is the source of IαI,
assays for HCs and TSG-6 were done and showed that AECs synthesize TSG-6 and
their own heavy chain donor (pre-IαI) with a single heavy chain 3 (HC3), which is the
substrate for transfer to HA to form the H3-HA rafts. This HC3 pre-IαI is also
constitutively expressed by human renal proximal tubular epithelial cells. These
leukocyte adhesive HC3-HA structures were also found in the bronchoalveolar lavage
(BAL) of naïve mice, and were observed on their apical ciliated surfaces. Thus, these
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leukocyte-adhesive HA rafts are now identified as HC3-HA complexes that could be
part of a host defense mechanism filling some important gaps in our current
understanding of murine airway epithelial biology and secretions.
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CHAPTER I
BACKGROUND
I.1. Hyaluronan
Hyaluronic acid or hyaluronan (HA) is an abundant glycosaminoglycan (GAG) in the
extracellular matrices (ECMs). GAGs are long, linear and heterogenous polysaccharides,
which consist of repeating units of disaccharides, with sequences that vary in
composition of the disaccharide unit, type of linkage and degree of acetylation and
sulphation. While most GAGs are attached to proteins and are highly sulfated (i.e.
heparin, heparan sulphate, dermatan sulphate, keratan sulphate and chondroitin sulphate)
[1], HA is uniquely a much larger, non-sulfated GAG, lacking a core protein. It is a linear
polymer of repeating disaccharides composed of D-glucuronic acid and D-Nacetylglucosamine linked by β (1,4) and β (1,3) glycosidic bonds [2]. HA is not simply
an inert structural molecule. Rather, it is implicated in many physiological and
pathological tissue responses such as ovulation and fertilization, embryonic development,
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tissue fluid homeostasis, inflammation, tissue repair and remodeling, tumor progression
and metastasis [3]. HA is synthesized by membrane-bound synthases on the inner surface
of the plasma membrane with the chains being extruded through pore-like structures into
the ECM. There are three mammalian hyaluronan synthases (HAS1-3). They incorporate
UDP-sugars (UDP-N-acetyl-D-glucosamine and UDP-D-glucuronate substrates) onto the
non-reducing end of the growing chain [4,5].

I.2. TSG-6 Mediated Hyaluronan Modification
Tumor necrosis factor α (TNFα) induced protein-6 (Tnfaip6), also known as
TNFa stimulated gene-6 (TSG-6), is a member of the hyaladherin family (HA binding
proteins). TSG-6 is a 35 kDa secreted protein that is not constitutively expressed in most
normal adult tissues but is rapidly induced in many different cell types such as
monocytes, fibroblasts, vascular smooth muscle cells, synoviocytes, chondrocytes, and
proximal tubular epithelial cells by inflammatory mediators such as interleukin-1 (IL-1)
and TNFα, lipopolysaccharides and prostaglandin E2 [6,7]. It consists of two domains:
the N-terminal link (link module) through which it binds to HA and the C-terminal
(CUB) domain of uncertain function [8]. Besides binding to HA, it can also bind to
several components of the ECM including chondroitin-4-sulfate (C4S) and inter-αinhibitor (IαI). IαI is a proteoglycan produced by liver hepatocytes and released in the
serum. It is composed of the trypsin inhibitor bikunin with heavy chain 1 (HC1) and
heavy chain 2 (HC2) that are covalently bound by ester linkages to bikunin via its single
chondroitin sulfate chain [9]. During inflammation, IαI can ingress into extracellular
tissue spaces as a consequence of increased vascular permeability where it serves as a
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heavy chain donor. TSG-6 catalyzes the transfer of HC1 and HC2 from IαI to HA,
forming the HC-HA complex [Fig. 1] [10,11].

Fig. 1. A Modified Schematic Illustration of the Heavy Chains Transfer to
Hyaluronan via TSG-6. Inter-α-Inhibitor (IαI) has two HCs (HC1 and HC2) attached
by ester bonds to N-acetyl-galactosamine residues in the chondroitin sulfate (CS)
chain on bikunin. TSG-6 removes a HC from IαI to form a HC-TSG-6 intermediate
and transfers it to form an ester bond to a N-acetyl-glucosamine residue in HA. [15]

These HC-HA complexes have been identified in synovial fluids from patients with
rheumatoid arthritis, osteoarthritis [12], and in bronchial secretions of asthmatics [13].
Furthermore, the expression of TSG-6 is upregulated in inflamed synovial tissue of
arthritis [14] and in lungs of asthmatics [15]. The expression of TSG-6 is among the
genes upregulated > 4 fold in allergen-challenged patients [16] emphasizing the
important role TSG-6 has during inflammation. HC-HA matrices promote leukocyte
adhesion to HA matrices as demonstrated in pathological conditions, including,
rheumatoid arthritis [14], idiopathic arterial pulmonary hypertension [17,18] and asthma
[15].

	
   3	
  
	
  
	
  

I.3. Pathological Hyaluronan Matrices
Adhesive HA structures on their cell surface with coalesced HA strands are referred to as
HA cables [19]. These modified HA cables have structural information recognized by
mononuclear leukocytes [20]. Leukocytes can bind to HA cables at 4° C [Fig. 2] and
rapidly phagocytose the matrix at a physiological temperature of 37° C [19, 20].

Fig. 2. Confocal Image of Leukocytes Bound to HA “Cable” Structures showing
CD44 “Capping.” Smooth muscle cells (colon) were treated with poly (I:C) to
induce the synthesis of HA “cable” structures (green) (panel A). U937 monocytic
leukocytes (CD44, red) bind these structures like “beads on a string” while not
adhering to HA “coats” found on the cell surface. At permissive temperatures (panel
B), the monocytic cells relocated, or “capped” CD44 to one pole and internalized HA
fragments as shown in the enlarged inset. CD44 capped leukocytes were also found
embedded in an HA matrix from an asthmatic lung biopsy (panel C). Nuclei are shown
in blue. (Mag. 100X) [19,20].
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These leukocyte adhesive HA matrices are seen in lung biopsies from asthmatic patients
[15] or in response to ER stress at physiological normal levels of glucose [21], and in
wound healing [22], idiopathic pulmonary hypertension [17,18], airway smooth muscle
cells in vitro [23, 24] and airway interstitial cells in mouse asthma models [15],
adipocytes in adipose tissue in a diabetic mice model [25,26] and renal tubular
endothelial stress [27,28]. The binding of leukocytes to HA cables is essential for its
removal, which occurs in a CD44-dependent manner [29]. This was demonstrated by
showing that CD44-/- mice subjected to bleomycin inhalation to induce inflammation
synthesized and accumulated HA matrix that couldn’t be removed by the influx of
monocytes and macrophages. Furthermore, the irradiated CD44-/- mice repopulated with
normal monocytes and macrophages, were able to remove this matrix after the bleomycin
treatment [30].
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CHAPTER II

MURINE AIRWAY EPITHELIAL CELLS RELEASE THE VAST
MAJORITY OF THEIR HYALURONAN APICALLY
II.1. ABSTRACT
Murine airway epithelial cells behave differently than any other cell type reported so far.
Besides making leukocyte adhesive HA cables that remain attached to the cell surface
when stressed, they can also uniquely release HA rafts from their apical surface into their
extracellular space. This unique release of HA occurs even when the cells are
unstimulated. This implies that synthesis of HA rafts may be a normal process of airway
epithelial biology, though it may be modified during periods of stress and inflammatory
stimuli. We have developed a physiologically relevant in vitro air-liquid interface (ALI)
culture model of murine primary airway epithelial cells that closely resembles the in vivo
airway epithelium. We used this model to characterize these cell-free HA rafts and the
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mechanism by which this chapter, we show that AECs constitutively release significant
amounts of HA from their apical surface over the course of their in vitro differentiation in
comparison to their basal compartment. HA released apically into the extracellular space
was of a wide range in size with a median of 495 kDa.
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II.2. INTRODUCTION:
II.2.1. Airway Epithelium and its Extracellular Matrix
The primary function of airway epithelium is to function as a physical barrier between the
external and internal environment. There are three barrier functions: (i) mucociliary
clearance by trapping and removing inhaled foreign particles from the airways [1], (ii)
intercellular apical junctional complexes that regulate epithelial pericellular permeability
[2], and (iii) secretion of antimicrobial substances such as enzymes, protease inhibitors,
oxidants, and antimicrobial peptides that kill inhaled pathogens [3,4].
The airway epithelium sits upon a specialized matrix structure called a basement
membrane. It is composed of type IV collagen, proteoglycans, laminins and [5]. The
basement membrane has several important roles in maintaining epithelial integrity: (i) it
acts as an anchor facilitating adhesion of epithelial cells; (ii) it establishes and maintains
correct cellular polarity, (iii) it acts as a barrier between the surface epithelium and the
underlying mesenchymal compartment, and (iv) it provides essential survival signals to
the epithelium [6].
II.2.2. Air-Liquid Interface (ALI) Culture Model of Murine Airway Epithelial Cells
We have developed a physiologically relevant in vitro air-liquid interface (ALI) culture
model of murine primary airway epithelial cells that closely resembles the in vivo airway
epithelium. Primary AECs are isolated from murine tracheas by limited proteolytic
digestion. After a series of purification steps, they are cultured on a native basement
membrane. This basement membrane on the transwell insert is pre-deposited by MadineDarby Canine Kidney (MDCK) epithelial cells. These steps are summarized as shown in
[Fig. 3].
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Fig. 3. A Schematic Illustration of the Main Steps in Murine Airway Epithelial Cell
Culture.
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After the AECs reach confluence, the culturing medium is removed (i.e. lifted) from the
apical chamber, creating an “air-liquid interface” which promotes the differentiation of
these cells into a mature, pseudostratified, and ciliated airway epithelium (10 – 14) days
following lift [Fig. 4] [7]. It is also very important at this point to note that these cells are
grown in serum free medium that lacks the source of IαΙ, the HC donor, and TSG-6.
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Fig. 4. Murine Airway Epithelial Cell Differentiation Time Course on Native Basement
Membrane. Toluidine blue staining of 1 µm epoxy embedded AECs were harvested 0, 3, 5, 7, 10,
and 14 days after exposure to an air-liquid interface (A-F, respectively). Differentiation progressed
from squamous (day 0) to cuboidal (day 3) to pseudostratified (days 5-14). Cilia formation was
apparent by day 5 and reached a plateau between 10 and 14 days. (Mag. 40 X, Magnification bar of
100 µm). [7]
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Fig. 5. Three-dimensional Confocal Images of Differentiated Murine Airway Epithelial Cells
Cultured on a Native Basement Membrane. Cilia are highlighted by β-tubulin IV staining (green),
and DAPI-stained nuclei are blue. (A) the apical surface of the epithelial cells (Mag. 63X). (B) a
lateral cross-section of the epithelial cells (magnification is ×63). (C) the apical surface zoomed from
63X to ~160X, where the gain for the green channel was lowered to highlight individual cilia. All
magnification bars are 50 µm. [7]	
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II.3. MATERIALS AND EXPERIMENTAL PRPCEDURES:

II.3.1. Materials:
100 mM ammonium acetate, pH 7.0, 400 mM Tris-acetate (T-6791, 500 g, MW 121.1;
Sigma Aldrich, TRIZMA BASE,), AMAC (2-aminoacridone) Solution (A-6289, 25 mg,
MW 246.7; Molecular Probes,), sodium cyanoborohydride (15615-9; Sigma Aldrich),
glacial acetic acid, 10x Proteinase K (Storeroom #155490, 100 mg; Invitrogen,),
Hyaluronidase, SD (100741-1A; Seikagaku) of a final concentration: 2.5 mU/µl,
Chondroitinase ABC (100330-1A; Seikagaku) of final concentration: 25 mU/µl,
Streptomyces hyaluronidase (100740-1; Seikagaku, East Falmouth, MA) of a final
concentration: 0.5 TRU/mL, 1X TBE (electorphoresis buffer), ammonium persulfate
(161-0700, 10 g; BioRad), TEMED (N,N,N’N’-Tetra-methylethylenediamine) (1610801; BioRad), Select HATM Hi ladder (HL0503; Hyalose, Oklahoma), Select HATM Lo
ladder (LL0401; Hyalose, Oklahoma), Mega- HATM ladder (200505; Hyalose, Oklahoma,
ML),

Stains

all

(1-Ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazolin-2-ylidene)-2-

methylpropenyl]naphtho[1,2-d]thiazolium

bromide,

3,3′-Diethyl-9-methyl-4,5,4′,5′-

dibenzothiacarbocyanine) (E9379; Sigma Aldrich).

II.3.2. Mice:
All mice were maintained in the Biological Resource Unit of the Cleveland Clinic Lerner
Research Institute in a temperature-controlled facility with an automatic 12 h light-dark
cycle and were given free access to food and water. All animal protocols were approved
by the Institutional Animal Care and Use Committee of the Cleveland Clinic. TSG-6-/	
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mice [8] were a generous gift from Dr. Tibor T. Glant (Rush University Medical Center,
Chicago, IL), and (4-6)-week-old female TSG-6 -/- mice were used. Wild-type controls
on a BALB/c background were purchased from Jackson laboratories and used for
preparing airway epithelial cell cultures.

II.3.3. MDCK basement membrane:
Basement membranes on the transwells were generated by applying Madin-Darby canine
kidney (MDCK) cells to the surface of the porous membranes of 12-well tissue culture
inserts (353180; BD Falcon). After reaching confluence, the MDCK cells were removed
by detergent lysis using PBS with 0.5% IGEPAL® CA-630 (I8896; Sigma) leaving
behind a native basement membrane on the transwell surfaces. The basement membranes
on the inserts were washed three times to ensure complete removal of the cellular debris.
This method is similar to our previous method for basement membrane formation, with
the exception that the basement membrane is not synthesized on a collagen matrix [7].
We found that the absence of the performed collagen layer did not hinder the AEC
adhesion and that the AECs grew more uniformly in the absence of collagen layer.

II.3.4. Primary Cell Culture:
After the mice were sacrificed using either pentobarbital or isofluorane, the tracheas were
excised from the mice and placed in Ham's F-12 nutrient medium with 50 units/ml
penicillin, 50 µg/ml streptomycin, and maintained at 4° C on ice. Under a dissecting
microscope, the esophagus and surrounding connective tissue were removed. The
tracheas were cut longitudinally with a scalpel to expose the lumen and transferred to 5
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ml of 0.15% pronase (10165921001; Roche Applied Science) in Ham's F-12 nutrient
medium with 50 units/ml penicillin and 50 µg/ml streptomycin for an overnight
incubation at 4° C in a 15-ml centrifuge tube. The next day, fetal bovine serum (FBS)
was added to the tracheas (final concentration 10%) to inhibit further protease
degradation. The medium, containing the released epithelial cells, was transferred to a
50-ml centrifuge tube. Washing medium (5 ml), containing Ham's F-12 nutrient medium
with 50 units/ml penicillin, 50 µg/ml streptomycin, and 10% FBS, was added to the
tracheas. The 15-ml centrifuge tube, containing the tracheas, was inverted several times
to dislodge remaining epithelial cells. The supernatant was pooled with the original
isolate, and the washing step was repeated twice, pooling all supernatants. The pooled
epithelial supernatants were centrifuged at 300 × g for 10 min. The pellet was
resuspended in 2 ml of Ham's F-12 nutrient medium with 50 units/ml penicillin, 50 µg/ml
streptomycin, 10 mg/ml bovine serum albumin (BSA) (BP-1605-100; Fisher), and
pancreatic DNase I (0.5 mg/ml) (DN-25; Sigma), and was incubated for 5 min on ice
before it was centrifuged at 300 × g for 5 min. The pellet was resuspended in 12 ml of
DMEM/F-12 with 100 units/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml
amphotericin B, 20 mM L-glutamine, and 10% FBS and transferred to a 100-cm2 Petri
dish and incubated at 37° C, 5% CO2, and 100% humidity for 3 h to allow for the
attachment of any contaminant smooth muscle cells or fibroblasts onto the dish.
Afterwards, the culturing medium, containing the non-adherent epithelial cells, was
transferred to a 10-ml tube. The adherent cells were washed once with 5 ml of medium to
remove remaining non-adherent epithelial cells and pooled with the first isolate. The
purified epithelial cells were centrifuged at 300 × g for 10 min. The pellet was re	
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suspended at 100,000 cells/ml in DMEM/F-12 medium containing 100 units/ml
penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B, 20 mM L-glutamine, 5
mM glucose (physiological levels), 5% FBS, 10 µg/ml insulin (I-6634; Sigma), 5 µg/ml
transferrin (T-1147; Sigma), 0.1 µg/ml cholera toxin (C-8052; Sigma), 25 ng/ml
epidermal growth factor (354001; BD Biosciences), 30 µg/ml bovine pituitary extract (P1476; Sigma), and 80 nM retinoic acid (R-2625; Sigma). The cells were seeded onto the
basement membrane-covered tissue culture inserts at 50,000 cells/well of a 12-well plate.
AECs were cultured with medium replacement every other day. After the AECs reached
confluence, which is normally within 6-7 days from the day they were seeded on
transwell inserts, the culturing medium is removed (i.e. lifted) from the apical chamber.
This lift promotes the differentiation of these cells into a mature, pseudostratified and
ciliated airway epithelium by day 10 after lift.
II.3.5. Immunohistochemistry
Paraffin embedded sections of lung tissues were previously fixed overnight in 10%
formalin. The sections were rehydrated in PBS for 30 min and then blocked with 1%
BSA in PBS. HA was labeled with a HA biotinylated binding protein (HABP) (5 µg/mL;
385911; EMD Chemicals, Gibbstown, NJ) in blocking solution, and then with
streptavidin conjugated to Alexa Fluor® 488 (1:500, product S11223; Invitrogen,
Carlsbad, CA). These slides were simultaneously incubated with anti-KDEL (PA1-013;
Affinity Bioreagents, Golden, CO) conjugates with Alexa Fluor® 594 secondary
antibody (1:500, product A21203, Invitrogen, Carlsbad, CA). Vectashield mounting
medium with DAPI (H-1200; Vector Laboratories, Burlingame, CA) was applied to the
apical surface of the samples followed by coverslip application before visualizing using
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fluorescent microscopy.

II.3.6. Apical Washes Collection:
After the culturing medium is removed apically on day 10 of lift, the AECs are being
cultured on an air-liquid interface, and the apical surfaces are gently washed every other
day with 200 µL of phosphate buffered saline (PBS) per insert of a 12-well plate. Apical
washes were pooled and frozen at -80° C until the time of use.
II.3.7. Fluorophore-Assisted - Carbohydrate Electrophoresis (FACE)
HA contents in the apical washes and basal media were measured by FACE as previously
described [9].	
  This technique was developed in our laboratory and has many advantages
over other methods of HA analysis since it can be used to quantify picomolar amounts of
HA from multiple samples using common vertical gel electrophoresis equipment.
Briefly, 10X Proteinase K was added to the apical washes or basal conditioned media and
mixed to give a final concentration of 1X PK then incubated at 37° C overnight. 4
volumes of pre-chilled (–20° C) 200 proof ethanol was added to each sample, which were
then incubated at – 20° C overnight. Next day, samples were centrifuged at 14,000 g for
10 minutes at RT. Supernatants were discarded, and the pellets, which contained the
glycosaminoglycans, were washed by adding 4 volumes of pre-chilled (–20° C) 75%
EtOH followed by a short vortex/spin. Samples were then centrifuged at 14,000 g for 10
minutes as before. Washes were discarded as before, with the residual ethanol removed
with a pipet. The pellets were dried at RT for 20 minutes. 35 µl 100 mM ammonium
acetate was added to each sample followed by a vortex/spin, and then incubated at RT for
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20 minutes followed by a vortex/spin. The PK was heat inactivated by incubating the
samples at 100° C for 5 min, which were then chilled on ice for 5 min. 1 µl of
chondroitinase ABC and hyaluronidase SD was added to each 35 µl sample to digest the
hyaluronan and chondroitin sulfate followed by a vortex/spin, and then incubated at 37°
C overnight (at least 18 hrs). 160 µl of pre-chilled (–20° C) 200 proof ethanol was added
to each sample followed by a vortex/spin, and then incubated overnight at –20° C.
Samples were centrifuged at 14,000 g for 10 minutes at RT. Supernatants were saved in a
separate 1.5 ml tube (Note: hyaluronan and chondroitin sulfate disaccharides are now in
the supernatant; heparan sulfate, nucleic acids and other carbohydrates are in the
pellet). The pellets were then washed with 160 µl of pre- chilled (–20° C) 75% ethanol
and centrifuged as before. Washes were pooled with the previous supernatants for each
sample. Pooled supernatants of each sample were lyophilized (using a “Speed-Vac” or
equivalent), and 2.5 µl of the AMAC solution was added to each sample and incubated at
37° C for 18 hrs in the dark. The samples were run on a gel prepared by mixing 5 mL of
(500 mL 40% acrylamide (37.5:1) (161-0148; BioRad), 100 ml Tris-Acetate (400 mM,
pH 7.0), 370 ml distilled water and 25 ml of glycerol) with 25 µl ammonium persulfate
(10%) and 5 µl TEMED. The run of the gel was at 500 V constant voltage for 55 minutes
using the BioRad Mini- PROTEAN® Tetra Cell.
A detailed protocol is found on our Program of Excellence in Glycosciences at Cleveland
Clinic webpage:	
  	
  
http://pegnac.sdsc.edu/cleveland-clinic/files/PEGNAC_FACE_Prot_GAGsv1_1.pdf
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Images of the gels were taken using myECL Imager (Thermo Scientific), and the band
intensities were quantified using ImageJ software that can be downloaded using the link:
http://imagej.nih.gov/ij/

II.3.8. HA sizing
10X Proteinase K was added to pooled apical washes, from 12 transwell inserts of AECs
every other day during the time course of their differentiation, and mixed to give a final
concentration of 1X PK, and then incubated at 37° overnight. 4 volumes of ice cold 200
proof ethanol were added to the samples followed by a Vortex/Spin and then incubated
overnight at -20o C. The samples were centrifuged at 13,200 g for 10 min, and the
supernatants were decanted. The pellets were washed with 1 ml ice cold 75% ethanol
and centrifuged as before, and then air dried for 20 minutes before re-suspending them in
0.1 ml of 100 mM ammonium acetate (pH 7.0). The proteinase K in the samples was heat
inactivated on a boiling water bath for 10 minutes, and then spun down. 3 µl of DNAse
(2224, 2 U/ul; Ambion) and 3 µl of RNAse A (109169, 1.28 mg/ml; Roche) were added
to each sample and incubated overnight at 37o C. The enzymes were heat inactivated on a
boiling water bath for 5 min and then spun. 400 µl cold 200 proof ethanol was added to
each sample and incubated overnight at -20o C. Samples were centrifuged at 13,200 g for
10 min, and then washed with 1 ml cold 75% ethanol and centrifuged as before. A p200
tip was used to remove any residual ethanol, and the pellet air-dried. Pellets were resuspended in 20 µl 100 mM ammonium acetate (pH 7.0) and transferred to a 200 µl PCR
tube. 1 µl of each sample was transferred to a separate tube and saved for subsequent
FACE analysis. 1 µl sialidase (N8271-0.2UN; Sigma) was added, and each sample was
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divided in half by transferring 9.5 µl to another tube to which 1 µl Streptomyces
hyaluronidase (100740-1, 0.2 TRU/µl stock; Seikagaku) was added and incubated
overnight at 37oC. The other half was incubated without the enzyme. The enzymes were
heat inactivated on a boiling water bath for 5 minutes and then spun down. The samples
were lyophilized by “Speed-Vac” and re-suspended in 10 µl of 10 M formamide (F-476,
10 M; Sigma-Aldrich,), and then incubated overnight at 4o C. Samples are run on a 1%
agarose gel (SeaKem HGT Agarose, 50041; Cambrex) in 1x TAE that is pre-run for 6
hours at 80 V (constant voltage) to remove impurities that stain strongly with Stains-All.
2 µl tracking dye (0.2% bromophenol blue in 10 M formamide) was added to the
samples. The entire sample (now at 12 µl) was loaded to a well. The gels were run at 100
V (constant voltage) until the tracking dye has migrated about 75% the length of the gel
(1-1.5 hr). The gels are then transferred into a dish with 30% ethanol to equilibrate the gel
into ethanol, which prevents the formation of Stains-All precipitates, and then rocked for
1 hour. The ethanol was decanted and replaced with Stains-All solution (E-9379; Sigma)
for overnight incubation. The gel was totally covered to prevent light from degrading the
dye. The stain was removed and replaced with water followed by shaking for 1 hour. The
gel was briefly (less than 1 hour) exposed to light to decrease background as needed. The
gel was scanned on a standard color scanner.

II.3.9. PCR Analyses
RNA was isolated using the RNAeasy kit (74104; Qiagen), and cDNA was prepared
using Superscript @ First-Strand Synthesis System (11904-018; Invitrogen). Primers of
HAS 1-3 used are listed in [Table 1] as previously reported in Cheng et al [10]. The PCR
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conditions were 1 cycle at 94° C for 3 min, 40 cycles of 95° C for 30 sec, 55° C for 45
sec, 72° C for 1 min, followed by 1 cycle of 72° C for 1 min. These conditions were used
for all primers. PCR products were run on 3% ethidium bromide gels (E1510; Sigma) and
1% agarose gels (SeaKem® HGT Agarose, 50041; Lonza).

Table 1. The Sequences of the Polymerase Chain Reaction (PCR) Amplification Primers
Name of Primers

Primer Sequence

Expected PCR product

!-actin

5’-GGTCATCACTATTGGCAACG-3’
5’-ACGGATGTCAACGTCACACT-3’

133 bp

HAS1

5’!GGTGGTTACCGTGTCCAAGTAT-’3
5’-GAAGGTAAACTGAGTCCCCAGA-3’

120 bp

HAS2

5’-GGTCCAAGTGCCTTACTGAAAC-3’
5’-TGTACAGCCACTCTCGGAAGTA-3’

96 bp

HAS3

5’- AGACCGAGCTAGCCTTCCTAGT-3’
5’-TAATGGCCAGATACAGCATGAG- 3’

84 bp
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II.3.10. Statistical Analysis
Data are presented as the mean ± SEM; n is indicated in figure legends in representative
experiments.
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II.4. RESULTS AND DISCUSSION

II.4.1. HA rafts on apical surfaces of murine airway epithelial cells (AECs) in vivo and
in vitro.
HA is located on the apical surfaces (white arrows) of murine AECs as distinct clumps,
or HA rafts (green), that can be seen both in vivo on a normal WT epithelium [Fig. 6A]
and on an air/liquid day 10 AEC culture in vitro [Fig. 6B]. Furthermore, the air/liquid
AEC culture model closely resembles its in vivo counterpart, as previously shown [7] in
terms of its pseudo-stratification, cellular morphology, presence of cilia, and KDEL (a
Endoplasmic Reticulum marker) distribution. Thus, it represents a compatible model to
study the HA rafts that murine AECs make.
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Fig. 6. HA Rafts are Loosely attached to the Apical Surface of Murine Airway Epithelia in
vivo and on AEC Lift Cultures in vitro. Paraffin embedded sections of a murine airway
epithelium (A) in vivo, and a 10-day differentiated air/liquid AEC culture (B) in vitro, were
stained for HA with a fluorescent conjugate of a biotinylated HA binding protein (green).
Nuclei were stained with DAPI (blue) and for endoplasmic reticulum (ER) (red) with an
antibody against KDEL. The arrows indicate the apical HA rafts. HA is also apparent in the
basal areas with most of it in the underlying connective tissue in vivo. Images are from a
zoomed in micrograph (Mag. 63X , magnification bar of 5 µm).
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II.4.2. Murine AECs release the majority of HA from their apical surface.

The apical surfaces of air/liquid AEC cultures were gently washed during their course of
differentiation over 10 days and analyzed for HA [Fig. 7]. HA in the basal media was
also measured for comparison. The results indicate that the HA shown to be on the
surface [Fig. 6B] is loosely attached, and that only small amounts are present in the basal
medium. This implies that the synthesis of this loosely attached HA on the apical surface
of AECs, which also appears to be present in vivo [Fig. 6A], may be a normal process of
airway epithelial biology, though it may be modified during periods of stress and
inflammatory stimuli.
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Fig.7. Murine AECs release Most of their HA from their Apical Surface. The bar graph
shows the amounts of HA determined by FACE in the apical washes (black bars), and basal
media (grey bars) collected during the differentiation phase of AEC cultures (N=6). The values in
the apical washes are statistically greater p<0.01 than those in the basal media from 2 through 10
days of differentiation with apical washes taken every 2 days.
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II.4.3. Murine AECs release a wide range of HA sizes from their apical surface.

The size of HA varies between cell/tissue type and can have a profound effect on the
function of HA [11]. HA fragments generated by multiple mechanisms throughout the
course of inflammatory pathologies, elicit cellular responses distinct from intact HA [12].
Typically, the full-length polymer has a very high molecular mass, ranging from 105 to
107 Da. The high molecular mass HA serves as a space filler, osmotic buffer, and
viscoelastic structure [13]. Under certain physiological and pathological conditions, HA
oligosac- charides exhibit quite different biological activities from the polymers,
including induction of angiogenesis [14] and cell proliferation [15]. AECs uniquely
release the vast majority of their HA from the apical surface in comparison to what is
released basally during their differentiation time course. To determine the size of HA in
the HA raft, we analyzed the HA in the apical washes of murine WT AECs collected
every other day during their differentiation time. The size of HA of the HA raft is
variable and ranges between very high molecular weight HA to as low as 27 kDa with a
median of 495 kDa as shown in [Fig. 8]. This implies that AECs dynamically metabolize
the HA, synthesizing very high molecular weight (HMW) HA ranging between (15206100 kDa) and breaking it down by hyaluronidases into smaller fragments.
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Fig. 8. Hyaluronan Size Analysis by Agarose Profiling. The size of hyaluronan of the
HA raft is analyzed on a 1% agarose gel stained with Stains all. The agarose profiling
shows both high and low molecular weights (Hi and Lo HA) of hyaluronan standards.
Mega HA standards range between (1520 – 6100) kDa. The left lane shows a ladder of
HA MW standards. The Streptomyces hyaluronidase (hyase) specifically breaks down
the hyalronan into disaccharide units and was used in this experiment to demonstrate
that the detected smears on the gel are of hyaluronan composition.
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II.4.4. Murine AECs express HAS1-3 that are involved in the synthesis of HA rafts.

HA is synthesized by membrane-bound synthases on the inner surface of the plasma
membrane with the chains being extruded through pore-like structures into the ECM.
There are three mammalian hyaluronan synthases (HAS1-3) [16,17]. HAS2 is the most
crucial enzyme in HA synthesis since mice lacking the ability to express HAS2 die at
mid-gestation[18] while HAS1 or HAS3 knock-out mice show no effect on fetal
development [19].
AECs can express all three HAS isoforms especially HAS2 and HAS3 that are involved
in the HA synthesis as shown is [Fig. 9]. This HA could be part of the ECM of the AECs
but is mostly released into the extracellular space as HA rafts as shown in [Fig. 7].

!-actin

HAS1

HAS2

HAS3"

Fig. 9. Relative Gene Expression of Hyaluronan Synthases by AECs. Hyaluronan
Synthases (HAS) 1-3 expression of a 10 day murine AECs is shown by the ethidium
bromide stained PCR product of HAS1-3 separated on a 1% agarose gel. (N=3).
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CHAPTER III

MURINE AIRWAY EPITHELIAL CELLS MAKE LEUKOCYTE-ADHESIVE
HYALURONAN RAFTS LOCATED ON THEIR APICAL SURFACE

III.1. ABSTRACT
For the past decade, a variety of cell types were shown to synthesize leukocyte- adhesive
HA structures on their cell surface, which resemble braided rope made of individual HA
strands known as HA cables, in response to a variety of inflammatory stimuli. In all cell
types studied to date, the leukocyte-adhesive HA cables synthesized by these cells remain
attached to the cell surface. However, while AECs also form HA cables on their cell
surface in response to a variety of inflammatory stimuli, they also actively release a
majority of their leukocyte-adhesive HA structures into the extracellular space from their
apical surface even when they are not stimulated. In this chapter, we demonstrate that
AECs can make leukocyte adhesive HA rafts that are loosely attached to the cell surface
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because of the heavy chain (HC) transfer onto the HA raft that is mediated by TSG-6.
These structures are not only found in our in vitro culture model but also in vivo.
Leukocyte-,adhesive HA rafts were found in the bronchoalveolar lavage (BAL) of naïve
wild type mice, and were observed on their apical ciliated surfaces. HA rafts were also
found in the BAL of a TSG-6 null mouse, but the HC transfer onto the HA was absent.
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III.2. INTRODUCTION
HA “cables” were first identified as HA rope-like structures that were attached to the
surfaces of colon smooth muscle cells treated with poly (I:C), a viral mimic, and that
promote leukocyte adhesion [1]. HA “cables” formed at the cell surface of a variety of
cells in response to a variety of inflammatory stimuli and function as a ligand for
inflammatory cells. We have previously found that transfer of HCs during the formation
of these HA “cable” structures on airway smooth muscle cells (ASMCs), upon treatment
with poly (I:C), stabilizes them, resulting in a more pronounced cable formation which
promotes greater leukocyte adhesion [Fig. 10] [2]. The addition of TSG-6 catalyzed the
transfer of HCs from IaI present in the serum in the medium onto the HA that is being
induced by poly (I:C) treatment. Leukocytes adhesion to these cables is in a HCindependent manner as shown in [Fig. 10B and 11], but substitution of these cable
structures with HCs significantly promoted leukocyte adhesion as shown in [Fig. 10C].
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Fig. 10. The HC-HA Complex promotes Leukocyte Adhesion to HA Cables.
Confocal images showing mononuclear U937 leukocytes (red with CD44 staining) bound
to HA cables in ASMCs (green, with hyaluronan binding protein staining), induced by
poly (I:C), or a combination of poly (I:C) and TSG-6 compared to untreated controls
(NT). Nuclei are blue (DAPI staining). The addition of TSG-6 significantly enhanced
leukocyte adhesion to HA cable structures via the formation of the HC-HA complex [2].
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Fig. 11. Addition of HCs to HA Cables via Recombinant TSG-6. HA “cables”
produced by ASMCs in response to poly (I:C) lack the HC modification. The addition of
recombinant TSG-6 was used to artificially add HCs to HA “cables” to form the HC-HA
complex. (A) Confocal images of ASMCs probed with an antibody against HCs (red)
with nuclei in blue (Mag. 63x). (B) Western blot of Strepotmyces hyaluronidase extracts
from these cables, thereby releasing the HCs (green) into the extract (N = 3) [2].
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AECs produce leukocyte adhesive HA “cables” like other cell types in response to
inflammatory stimuli such as tunicamycin, which results in an endoplasmic reticulum
(ER)-stress [Fig. 12] [3]. Interestingly, we report for the first time the release of
leukocyte- adhesive HA rafts from the apical surface of AECs that occurs in the absence
of inflammatory stimuli. This implies that the synthesis of HA rafts is a part of normal
respiratory secretions by AECs.

B.
Fig. 12. U937 Monocytic Cells bind to Hyaluronan on the Apical Surface of
Differentiated Murine Airway Epithelial Cells treated with Tunicamycin. CM-DiIlabeled U937 cells (red) were applied to the apical surface of epithelial cells treated
without (A) or with tunicamycin (B). Hyaluronan (green) was labeled with fluorescencetagged streptavidin on a biotinylated hyaluronan binding protein. (Mag. 40X,
magnification bar of 100 µm) [3].
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III.3. MATERIALS AND EXPERIMENTAL PROCEDURES

III.3.1. Mice
As described in section II.3.2. [4].

III.3.2. Apical Washes Collection

Apical washes were collected by gently washing the apical surface of differentiated AEC
cultures of day 10 after lift, removal of apical media, with 500 µL of phosphate buffered
saline (PBS).

III.3.3. Leukocyte Binding to Apical Washes Collected from AEC cultures

U937 cells, a human monocytic leukocyte cell line, suspended in RPMI medium with 100
units/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B and 20 mM Lglutamine were used for this binding assay. Around 50,000 U937 cells were incubated
with 500 µL apical wash, which was collected from a day 10 AEC culture, for an hour at
4° C then transferred to a glass slide via cytospin and left to air dry completely before the
processing for immunohistochemistry [Fig. 13].
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500 µL apical wash of a differentiated
airway epithelial cells ( day 10)
+!
U937 cells ( human leukocyte cell line)
1. incubated with the apical wash for an hour at 4° C

2. transfer onto a glass slide
via cytospin
3. leave to air dry completely

Fig. 13. A Schematic Illustration of the Main Steps in U937 Cells Binding Assay to
the HA rafts in vitro.
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III.3.4. Bronchoalveolar Lavage (BAL) Collection

Mice were euthanized by using isofluorane or pentobarbitol. BALs were obtained by
cannulating the trachea with a 24 gauge-feeding needle and lavaging the lungs with 600
µL of PBS. The typical BAL fluid returned was 400-500 µL. A 100 µL aliquot of the
collected BAL was transferred to a glass slide via cytospin and left to air dry completely
before processing for immunohistochemistry.

III.3.5. Immunohistochemistry
Aliquots of BAL or apical washes from day 10 AEC cultures were transferred to a glass
slide via cytopsins and were air dried completely. Samples were then fixed with 100%
methanol at -20° C for 10 min and air dried for 1 h. Methanol fixed cytospins of BAL and
apical washes of AECs were rehydrated in PBS for 30 min and then blocked with 1%
BSA in PBS. HA was labeled with a HA biotinylated binding protein (HABP) (5 µg/mL;
385911; EMD Chemicals, Gibbstown, NJ) in blocking solution, and then with
streptavidin conjugated to Alexa Fluor® 488 (1:500, product S11223; Invitrogen,
Carlsbad, CA). These slides were simultaneously incubated with a cocktail of antibodies
to HC1, HC2 and HC3, using Alexa Fluor® 594 donkey anti-mouse secondary (1:200;
product A11058; Invitrogen) or anti-CD44 (1:250; product C7923, Sigma-Aldrich, St.
Louis, MO) or anti-KDEL (PA1-013; Affinity Bioreagents, Golden, CO). Vectashield
mounting medium with DAPI (H-1200; Vector Laboratories, Burlingame, CA) was
applied to the apical surface of the samples followed by coverslip application before
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visualizing using fluorescent microscopy.

III.3.6. Western Blot Analysis
Samples were electrophoresed on 10% SDS–PAGE and transferred onto Immobilon-P
membranes (Millipore). All blots were blocked for 1 h with 5% milk (Blotting Grade
Blocker, 170-6404; BioRad) and probed overnight at 4° C with antibodies against HC1
(SC-33944; Santa Cruz Biotechnology), HC2 (SC-21978; Santa Cruz Biotechnology),
HC3 (SC- 21979; Santa Cruz Biotechnology), and IαI (A0301; Dako Cytomation,
Denmark). Blots were washed with 1X Tris Buffered Saline (TBS) with TWEEN®20
(0777-2 L; AMRESCO) 3 times for 7 minutes each time. Blots were then incubated with
donkey anti-goat IgG-HRP (SC-2020; Santa Cruz Biotechnology) as secondary antibody
for 1 h at room temperature then washed again for three times for 7 minutes each time.
TSG-6 was assessed using a biotinylated anti-mouse TSG-6 antibody (BAF2326; R&D
systems, Inc.) followed by the treatment with streptavidin-horse radish peroxidase (HRP)
(P0397; Dako Cytomation) for 1 h at room temperature. Recombinant mouse TSG-6
(2326-TS; R&D systems, Inc.) was used as a positive control for the TSG-6 antibody. All
blots were developed using the ECL Prime Western Blotting Detection Reagent
(RPN2232, Amersham) and detected protein band intensities were measured using
ImageJ software (http://imagej.nih.gov/ij/). Protein standards (Fermentas Page Ruler
Prestained Protein Ladder, SM0671; Thermo Pierce) were used with each gel that was
run.
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III.3.7. Hyaluronidase Extraction of HCs from the HC-HA Complex
HCs were determined in bronchoalveolar lavage (BAL) samples and in apical washes of
10 day air/liquid interface cultures of primary differentiated AECs by treatment with or
without Streptomyces hyaluronidase (0.5 TRU/mL; 100740-1; Seikagaku, East Falmouth,
MA) overnight at 37° C. The supernatants were then analyzed by Western blotting.

III.3.8 Statistical Analysis

Data are presented as the mean ± SEM; n is indicated in figure legends in representative
experiments.
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III.4. RESULTS AND DISCUSSION
III.4.1 Murine AEC cultures release leukocyte adhesive HA rafts from their apical
surface.
HA cables are formed at the cell surface of a variety of cells including AECs [5] during
inflammatory processes. These structures are known to function as a ligand for
inflammatory cells [1]. However, the majority of the apical HA produced by AECs can
be released into the extracellular space as HA rafts. To investigate whether these rafts are
also leukocyte adhesive, we incubated the apical washes of 10 day AEC cultures with a
human cell line of monocytic U937 cells for an hour at 4° C. Subsequently, an aliquot
was transferred to a slide via cytospin, and stained for CD44, a HA receptor. Multiple
clusters of U937 cells were embedded in the HA rafts as shown in [Figure 14A-C].
Murine AECs behave differently than any other cell type reported so far. Besides making
leukocyte adhesive HA cables that remain attached to the cell surface in response to a
variety of inflammatory stimuli, they also actively release a majority of their HA matrices
into the extracellular space from their apical surface. These matrices do not resemble the
rope-like HA cables, but occur in distinct sheets or rafts of HA that are leukocyteadhesive.
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D. Secondary antibodies only

Fig. 14. Leukocyte-Adhesive HA Rafts in vitro. (A-C) Monocytic U937 cells were
suspended in the apical wash from a 10 day AEC culture for 1 h at 4o C and subsequently
cytospinned onto a slide. HA was stained with a fluorescent conjugate of biotinylated HA
binding protein (green). U937 cells were probed with antibodies against CD44 (red). This
fluorescent micrograph shows multiple clusters of U937 cells embedded in HA rafts
(Mag. 20X). (N=3).
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Furthermore, similar adhesion of U937 cells was observed when they were added to the
apical surface of an AEC culture [Fig. 15]. This indicates that the HA rafts released by
the AECs are also leukocyte-adhesive similar to the HA cables that are known to form in
other pathologies. However, in this case, they are not being formed in response to a
pathological stimulus.
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Fig. 15. Murine AECs release Leukocyte-Adhesive HA Rafts from their Apical
Surface. The micrograph of a section of non-stimulated 10 day AEC culture (Mag. 63X,
magnification bar of 10 µm) shows an example of U937 monocytes (g) binding to the
loosely attached HA raft (h).
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A. DAPI

B. CD44
50 µm

D. Overlay + DAPI

C. HA

Fig. 16. U937 Cells don’t cluster in the Absence of HA Rafts. (A-D) U937 cells in
RPMI medium were transferred to a glass slide after one hour incubation at 4o C without
the addition of day 10 AEC culture’s apical wash that contains the HA rafts. Absence of
HA was shown by lack of staining with a fluorescent conjugate of biotinylated HA
binding protein (green). U937 cells were probed with antibodies against CD44 (red). This
fluorescent micrograph shows that U937 cells don’t cluster, as in [Fig. 14], in the absence
of HA rafts due to the centrifugal force resulting when the cells are transferred to the
glass slide via cytospin. (Mag. 20X, magnification bar 50 µm). (N=3).
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III.4.2. HA rafts contain HC-HA complexes.
One possible explanation for the HA adhesiveness to leukocytes is due to a HA
modification that often occurs during inflammations, namely the transfer of HCs from IαI
to form HC-HA complexes, which is mediated by TSG-6 [6,7]. Apical washes of 10 day
AEC cultures were collected at the indicated times (2-48 h) after replacing the medium
on day 10. They were then treated with Streptomyces hyaluronidase (specific for HA
digestion into disaccharides) and analyzed for HCs by Western blots [Fig. 17A]. The
accumulation of HCs at ~85 kDa over the time course is apparent. This band was not
present in the absence of the hyaluronidase digestion as shown in the analysis of a 12 day
apical wash [Fig. 17C]. This provides evidence that monocyte binding is due to a large
extent by the presence of HCs [8,9], and that the HA rafts contain HC-HA complexes.
Furthermore, TSG-6 was also present in the apical washes and absent in apical washes
from TSG-6 null AECs [Fig. 17B]. The absence of HC-HA in the TSG-6 null cultures is
also apparent [Fig. 17A].
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Fig. 17. Murine AECs make HA rafts that contain HC-HA complexes. Western blots
of apical washes of unstimulated AECs were collected at 2, 4, 8, 24 and 48 h after day 10
of their differentiation and treated with Streptomyces hyaluronidase (S. hyase) and then
(A) probed with a cocktail of HC1, 2 and 3 antibodies, and (B) re-probed with TSG-6
antibody. Absence of HC transfer and TSG-6 from a parallel experiment with AECs from
TSG-6 null mice is apparent in (A) and (B) consecutively. (C) Western blot of an apical
wash collected on day 10 of differentiation, 48 h after the previous apical wash, treated
without or with S. hyase. This blot was probed with an antibody against IαI.
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III.4.3. HA rafts in murine bronchoalveolar lavage (BAL) require TSG-6 for HC
transfer onto HA. To determine whether HA rafts are HC-HA complexes released by the
airway epithelium in vivo, we analyzed BAL samples from a naïve WT mouse and found
clusters of HA that are monocyte adhesive similar to the HA rafts that AECs make in
vitro as shown in [Fig. 18A-C]. Furthermore, these HA rafts lacked HCs in the absence
of TSG-6 as shown in the BAL collected from a TSG-6 null mouse [Fig. 18D-F], which
is consistent with the fact that HC transfer onto HA requires TSG-6. Moreover, the size
of the HA raft in the TSG-6 null BAL fluid was much smaller, suggesting that the lack of
TSG-6 may have an effect on the synthesis or aggregation of HA. This is consistent with
the significant decrease of pulmonary HA concentration measured in the BAL and lung
tissues of TSG-6 null mice subjected to the ova asthma model [10].

Furthermore,

digesting the BAL collected from naïve WT mouse with S. hyase resulted in the release
of significantly more HCs into the gel that were detected on Western blots [Fig. 19A,B]
while HC bands were nearly absent (<10% of control) in BAL from a TSG-6 null mouse.
This demonstrates the role of TSG-6 in mediating HC transfer onto HA in rafts located
on the apical surface. Moreover, we have previously shown that TSG-6 can transfer all
of the HCs from serum-derived HC-bikunin to HA1000K in vitro at early time points
while TSG-6 released free HCs from HA1000K at later time points to a lesser extent [11].
This may explain the observation of free HCs in the presence of TSG-6 when WT BAL
was not treated with S. hyase.
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Fig. 18. HA Rafts in Murine BAL require TSG-6 for HC Transfer onto HA. HA
rafts are present in BAL from naïve wild type (WT) (A-C) and from TSG-6 null mice (DF). HA was stained with a fluorescent conjugate of biotinylated HA binding protein
(green), and the presence (B) and absence (E) of the HC-HA complex was shown by
staining with a cocktail of HC1, 2 and 3 antibodies (red). Leukocytes were stained with
DAPI (blue). (Mag. 20X, magnification bar of 50 µm).
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Fig. 19. HC-HA Complex is found in BAL of Naïve WT and not in that of TSG-6
Null Mice. (A) One representative out of 3 Western blots of BAL from naïve WT and
TSG-6 null mice that were incubated without or with S. hyase. (B) Bar graph
representation of the HCs released by S. hyase indicates the amount of HC-HA in BAL
from naïve WT mice, which is absent in the BAL of TSG-6 null mice (N=3).
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CHAPTER IV

MURINE AIRWAY EPITHELIAL CELLS CONSTITUIVELY
SYNTHESIZE THEIR OWN HEAVY CHAIN DONOR AND
TSG-6
IV.1. ABSTRACT

The HC-HA modification involves the transfer of heavy chains from the inter-α-inhibitor
(IαI) proteoglycan, which has 2 heavy chains (HC1 and HC2) on its chondroitin sulfate
(CS) chain. The transesterification transfer of HCs from CS to HA is mediated by tumornecrosis-factor-induced-gene 6 (TSG-6), which is upregulated in inflammatory reactions.
IαI, the heavy chain donor, is normally produced by liver hepatocytes and released into
the plasma. Very few other cell types have been reported to constitutively express their
own heavy chain donor. In this study, we show that murine AEC cultures synthesize
TSG-6 and their own heavy chain donor (pre-IaI) with a single heavy chain 3 (HC3)
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linked to a bikunin as HC3-bikunin, which are also constitutively expressed by human
renal proximal tubular epithelial cells. Therefore, AECs synthesize HC3-bikunin to act as
a HC donor that is involved in the HC transfer mediated by TSG-6 onto the HA forming
HC3-HA rafts. These HC3-HA rafts that are located on the apical surface of AECs are
leukocyte adhesive. Thus, these leukocyte-adhesive HA rafts are now identified as HC3HA complexes that could be part of a host defense mechanism filling some important
gaps in our current understanding of murine airway epithelial biology and secretions.
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IV.2. INTRODUCTION
IV.2.1. Inter-trypsin-α-Inhibitor (IαI) Family
In mammals, the bloodstream is a major carrier for many glycoproteins that act as
protease inhibitors. Inter-α-inhibitor (IαI) and related molecules, collectively referred to
as the IαI family, are a fascinating group of such plasma protease inhibitors. The
discovery of an increasing number of such molecules has raised numerous questions
about their pathophysiological functions [1]. Until recently, the knowledge of the IαI
family was mostly structure oriented. Indeed, IαI was for many years described as a
single entity, and a major breakthrough in the late 1980s was the emergence of a set of
related molecules. At least four heavy chains (HCs) designated HC1, HC2, HC3 and HC4
[2-4], are involved in the synthesis of IαI family members [Fig. 20] [5,6].
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Figure 1 A current view of the IαI family, from genes to glycoproteins
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work). Symbols read as follows. mRNAs: thin line, non-coding sequence; black box, open reading frame. Precursor polypeptides: crossed box, signal peptide; hatched box, α1m; double-hatched
box, bikunin; black box, N-terminal cleavage product of H precursor; pink box, mature H chain; grey box, C-terminal cleavage product of H precursor. Glycoproteins: wavy line, covalent PGP
cross-link. Only the major members of the IαI family are depicted; for the sake of clarity, their former, usual, acronyms as well as the newly proposed nomenclature (see Table 2) are given.

Table 1 Sizes of the H1 to H4 precursor polypeptides and mature chains
HxP, precursor polypeptide; Hx, mature chain found in some IαI-related plasma proteins. The
sizes are expressed as the number of amino acid residues, as inferred from the cDNAs and
protein sequences published and/or discussed in [2,3,9,10,11,63,64]. The signal peptides as
defined in [2,3] are not included in the precursor sizes indicated. Note that the order H2P, H1P,
H3P, H4P, as shown, reflects the most closely related polypeptide pairs: H1P and H3P; H3P
and H4P [2–4]. A possible trimming of a 36-amino-acid propeptide at the N-terminus of
H2P [3,9] is included in the calculations. The H4P polypeptide can undergo some
cleavage steps after its secretion into plasma, eventually resulting in a major 633-amino-acid
peptide (see text and [2]). n.a., not applicable; n.d., not determined.
No. of amino acids
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trimming of their C-terminal ends, with removal of 240–280
amino acid residues (Figure 1; Table 1), as judged from the
sequences of the mature H polypeptides found in the purified
plasma proteins. Furthermore, the H2 precursor displays a
stretch of 36 amino acids located between its signal peptide and
the N-terminus of the mature H2 chain, which suggests a further
trimming of a propeptide at the H2 N-terminus [3,9,11] (Figure
1; Table 1). Based upon the N-terminal amino acid sequences of
the purified H chains [11] and alignment of the cDNA-deduced
sequences, the presence of a similar propeptide in the H1, H3 and
H4 precursors is unlikely, as discussed elsewhere [3].
In addition to the four H genes, another gene, designated the
α1-microglobulin (α1m)�bikunin precursor (AMBP) gene, is
involved in the synthesis of most IαI family members (Figure 1;
Table 2). The AMBP mRNA encodes a precursor for two
polypeptides, α1m and bikunin. The AMBP gene is comprised of
six α1m-encoding exons and four bikunin-encoding exons
separated by a large (7 kb) intron, suggesting that the modern
AMBP gene resulted from the fusion of two ancestral α1m and
bikunin genes [12]. As homologous AMBP mRNAs have been

IαI is an abundant proteoglycan produced by liver hepatocytes and released in the serum.
It is reported to circulate in serum at concentrations between 150 and 500 µg/mL
comprising ~5% of total protease inhibitory activity of plasma, and elevated levels are
reported in inflammatory pathologies [7,8]. It is normally composed of the trypsin
inhibitor bikunin with heavy chain 1 (HC1) and heavy chain 2 (HC2) that are covalently
bound by ester linkages to bikunin via its single chondroitin4-sulfate (C4S). The
chondroitin sulfate chain is linked through an ester bond between C-terminal aspartate
and the 6-hydroxyl of an N-acetylgalactosamine. The transesterification transfer of HCs
from C4S of the IαI to a 6-hydroxyl of an N-acetylglucosamine of HA is mediated by
TSG-6, a protein secreted by various cells upon stimulation by inflammatory cytokines
[9-16].

IV.2.2. TNFα Stimulated Gene-6 (TSG-6)
Tumor Necrosis Factor α (TNFα)-induced protein-6 (Tnfαip6) also known as TNFαstimulated gene-6 (TSG-6) is a member of HA binding proteins [17]. It is a 35 kDa
secreted protein that is involved in both physiological and pathophysiological tissue
responses. Besides interacting with HA [18-20], this protein also interacts with a broad
spectrum of GAGs and protein ligands, including C4S [21], heparin [22], IαI [23-24],
aggregan [25] and pentraxin-3 (PTX3) [26]. TSG-6 is produced by many different cell
and tissue types in response to a wide variety of stimuli [27]. The expression of TSG-6 is
induced by a number of factors other than TNF-α including IL-1β, TGF-β, and LPS in a
highly cell type-dependent manner, and in many cases is coordinated with the synthesis
of HA. TSG-6 expression has been observed in physiological and pathological contexts
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that are associated with inflammation and tissue remodeling, such as in the sera and joints
of arthritis patients [28]. Recently, the activity of TSG-6 in osteoarthritis synovial fluid
has been demonstrated as a biomarker for OA progression and the need for knee
replacement [29]. TSG-6 has a diversity of functions. It has been described to inhibit
neutrophil migration [30], has anti-inflammatory effects as it is considered
chondroprotective in murine model of arthritis [31], and has a major role in stabilization
of the HA matrix of the cumulus cell-oocyte complexes that is crucial for fertility [32].
Further, TSG-6 expression is among the genes upregulated > 4 fold in allergenchallenged patients as shown in [Table 2] emphasizing the important role that TSG-6 has
also during inflammation [33]. It has been shown that TSG-6 catalyzes the transfer of
HCs from the C4S chain to the N-acetyl-glucosamine (glcNAc) residues on the HA to
form HC-HA complexes that have been implicated in many pathological responses. HCHA complexes have been shown to accumulate within inflamed tissues and correlate with
disease severity [34,35]. During many pathological processes, these HC-HA matrices
contain structural information recognized by mononuclear leukocytes potentially
explaining the increased leukocyte binding [36,37].
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Following segmental allergen challenge of asthmatic individuals, TSG•addition
to the Th2 cytokines IL-3, IL-4 and IL-5, is one of 24 genes tha
induced four fold or more.

Table 2. Bronchial Epithelial Cell mRNAs with Fourfold or Greater Upregulated
Expression
after on
Allergen
(Effects of Allergen
Challenge
Airway Challenge
Epithelial Cell Gene Expression Craig M. Lilly, Hiroki Tateno, Tsuyoshi Oguma, Ellio
and Larry A. Sonna. Am J Respir Crit Care Med Vol 171. pp 579–586, 2005.)
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IV.2.3. Constitutive Expression of Heavy Chain Donors and TSG-6
At the present time, the only well characterized source of IαI is in the serum being
produced by the liver hepatocytes. Amniotic membrane (AM) is another tissue in
addition to the liver that constitutively produces IαI. The HC1-HA complex made by this
tissue is different from that found at inflammatory sites (e.g. in asthma and arthritis) that
potentially could explain for the anti-inflammatory, anti-scarring, and anti-angiogenic
actions of the AM [38].
In this study we show that AECs can synthesize their own heavy chain donor as HC3bikunin that is used for the HC transfer onto the HA without the requirement of serum
exudate that could occur during inflammation. This donor is the same as, the pre-IαI
made and secreted by renal epithelium, which is also composed of a bikunin with a HC3
covalently linked by an ester bond to the chondroitin-4-sulfate chain [39]. AECs can also
constitutively express TSG-6 without being stimulated with TNFα as shown is the results
section VI.4.
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IV.3. MATERIALS AND EXPERIMENTAL PROCEDURES

IV.3.1. Mice
As described in section II.3.2.
IV.3.2. Primary Cell Culture
As described in section II.3.4.
IV.3.3. Cell Lysate Preparation
200 µL of cold cell lysis buffer (1% Triton X-100, 40 mM HEPES, of pH 7.4, 300 mM
NaCl, 3 mM MgCl2, 4 mM EGTA), with protease (Complete Mini, 11826153001; Roche
Applied Science) and phosphatase (PhosSTOP, 04906845001, Roche Applied Sciences)
inhibitors, was added to the AECs cultured on transwell inserts at day 10 of their
differentiation. The AECs were lysed by pipetting the added volume of lysis buffer up
and down, and avoiding the formation of air bubbles as much as possible. The volume of
lysis buffer added was left on the transwell insert for 40 minutes on ice before it was
collected and spun down by centrifugation for 10 minutes at 14,000 g and at 4o C. The
supernatant was transferred to a new 1.5 mL eppendorf tube and then stored at -80o C till
the time of use. The samples were then processed for Western Blotting as described in
section IV.3.5.
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IV.3.4. Basement Membrane Protein Extraction
900 µL of 4x Laemmli Sample Buffer (161-0747; BioRad) was mixed with 100 µl βmercaptoethanol (BME) (161-0710; BioRad). 200 µl of this mix was added to one
transwell insert, which was has a pre-deposited basement membrane by MDCK cells as
described in section II.3.3. Extraction of the proteins of the basement membrane was
done by pipetting up and down the added volume of the sample buffer 3 times, before
transferring the same volume of sample buffer to the next transwell insert. This was
repeated to extract the proteins from a total number of 12 transwell inserts in a total
volume of 200 µL sample buffer with a final protein concentration of nearly 25 µg. This
was run on a gel as described in section IV.3.5, and stained for HC-3 and TSG-6 protein
detection as described in section IV.3.6 for protein detection on gel by Coomassie blue
staining.

IV.3.5. Western Blot Analysis
Samples were electrophoresed on 4-5% Mini-PROTEAN TGX gels (456-8084; BioRad)
and blotted using PVDF membranes (170-4156 – PVDF mini; BioRad) and the TransBlot Turbo System. All blots were blocked for 1 h with 5% milk (Blotting Grade
Blocker,170-6404; BioRad) and probed overnight at 4° C with antibodies against HC1
(SC-33944; Santa Cruz Biotechnology), HC2 (SC-21978; Santa Cruz Biotechnology),
HC3 (SC- 21979; Santa Cruz Biotechnology), and bikunin (a kind gift from Anthony
Day, University of Manchester, UK). Blots were washed with 1X Tris Buffered Saline
(TBS) with TWEEN®20 (0777-2 L; AMRESCO) 3 times for 7 minutes each time. Blots
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were incubated with secondary antibody, and Biotin-SP-conjugated donkey anti-goat IgG
was used as secondary antibody (705-065-147; Jackson ImmunoResearch), against
primary antibodies against HC1-3 for 1 h at room temperature. Blots were washed again
with 1X TBS with TWEEN®20 3 times for 7 minutes each time before the incubation
with streptavidin-horse radish peroxidase (HRP) (P0397; Dako Cytomation) for 1 h at RT
Blots were washed again with 1X TBS with TWEEN®20 3 times for 7 minutes each
time.
TSG-6 was assessed using a biotinylated anti-mouse TSG-6 antibody (BAF2326; R&D
systems, Inc.). Recombinant mouse TSG-6 (2326-TS; R&D systems, Inc.) was used as a
positive control for the TSG-6 antibody. All blots were developed using the ECL Prime
Western Blotting Detection Reagent (RPN2232, Amersham).

IV.3.6. Coomassie Blue Staining

The protein extracts of the basement membrane, deposited by the MDCK cells, were
electrophoresed on 4-5% Mini-PROTEAN TGX gels (456-8084; BioRad). The gel was
washed with distilled water for 10 minutes and then stained with Bio-Safe Coomassie
Stain (161-0786; BioRad) overnight. The gel was washed with distilled water every 10
minutes for 30 minutes before it was visualized using myECL imager from Thermo
Scientific.
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IV.3.7. PCR Analyses
RNA was isolated using the RNAeasy kit (74104; Qiagen), and cDNA was prepared
using Superscript @ First-Strand Synthesis System (11904-018; Invitrogen).	
   Primers
used are listed in (Table 3) below. The PCR conditions were 1 cycle at 94° C for 3 min,
40 cycles of 95° C for 30 sec, 55° C for 45 sec, 72° C for 1 min, followed by 1 cycle of
72° C for 1 min. These conditions were used for all primers. PCR products were run on
3% ethidium bromide gels (E1510; Sigma) and 1% agarose gels (SeaKem® HGT
Agarose, product 50041; Lonza).

Table 3. The Sequences of the Polymerase Chain Reaction (PCR) Amplification Primers
Name of Primers

Primer Sequence

Expected PCR product

!-actin

5’-GGTCATCACTATTGGCAACG-3’
5’-ACGGATGTCAACGTCACACT-3’

133 bp

Heavy chain 1

5’TTCTCAGCCCTTAGAGATGGTG’3
5’-GAGTGGCAACTTTGAGTCTATGG-3’

100 bp

Heavy Chain 2

5’-GGTGATAGAGAATGATGCTGGA-3’
5’-CAACCTTGGTGCCATAATACAG-3’

101 bp

Heavy Chain 3

5’- CCCAGAAAGATTACAGGAAGGA-3’
5’-TCGGTATGGACACCATCAATTA- 3’

100 bp

TSG-6

5’- CTCCATATGGCTTGAACAAGCAGC3’
5’- ACCACCTTCAAATTCACATACG- 3’

112 bp
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IV.4. RESULTS AND DISCUSSION
IV.4.1. Murine AECs make their own heavy chain3 (HC3) donor as HC3-bikunin
ΙαΙ is a proteoglycan that normally contains two HCs (HC1 and HC2). It is produced by
the liver hepatocytes where it is released into the serum at relatively high concentrations.
It serves as a HC donor for TSG-6 mediated transfer of HCs to HA during many
inflammations. The AEC culture medium lacks serum, the source of ΙαΙ, which is the
source of HCs. Therefore, the presence of HC-HA in the HA rafts from unstimulated
AEC cultures suggests that AECs can make their own HC donor.

From the three

different HC subtypes (HC1-3) analyzed by RT-PCR, murine AECs express only HC3, as
shown in [Fig. 21A]. [Fig. 21B] shows that the donor, which has a MW of ~132 kDa,
contains HC3 and bikunin, which is equivalent to the pre-IαI complex. This donor is the
same as the pre-IαI made and secreted by renal epithelium, which is composed of a
bikunin with a HC3 covalently linked by an ester bond to the chondroitin-4-sulfate chain
[9-16]. Therefore, AECs synthesize their own HC3-bikunin, in a manner similar to renal
epithelial cells, and are able to generate HC3-HA rafts without the requirement of a
serum exudate produced during inflammations.
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Fig. 21. Murine AECs make their Own Heavy Chain 3 (HC3) Donor as HC3Bikunin, a Member of the PαI/IαI family. (A) PCR products produced using primers
for the 3 heavy chain subtypes (HC1-3 as listed in Table 3), were prepared from mRNA
isolated from day 10 unstimulated murine AECs, and then separated on a 1% agarose gel
and stained with 3% eithidium bromide. β-actin mRNA production was used as the
housekeeping gene. One representative gel of 3 is shown. (B) Western blots of AEC
lysates demonstrate the presence of HC3 protein using a HC3 antibody (blot on the left).
Western blots with antisera to HC1 and HC2 were negative (data not shown). A
biotinylated secondary antibody (1:5000 dilution) was used after the primary antibody
application followed by a streptavidin-HRP (1:2000 dilution). The detected band has a
molecular weight of 132 kDa, equivalent to that of PαI (with one HC) of the IαI (with
two HCs) family. The blot in the right also labeled the 132 MW band when it was probed

	
  75	
  
	
  
	
  

with an antibody to bikunin, the core protein of IαI, providing evidence for the pre-IαI
member of the family that is HC3-bikunin.
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IV.4.2. TSG-6 is expressed by unstimulated murine AECs and released apically and
not basally.

The HC3-HA data in figures 5 and 6 provide evidence that AECs synthesize TSG-6 as
well as their own HC3-bikunin. Therefore, we isolated total cellular RNA isolated from
day 10 differentiated AECs and examined TSG-6 mRNA by RT-PCR. We used cellular
RNA isolated from mouse dermal fibroblasts, known to express TSG-6 only when treated
with TNFα [38], as our positive control [Fig. 22A]. Furthermore, we analyzed Western
blots of apical washes and basal media of AEC cultures for TSG-6 protein levels as
probed with a biotinylated mouse TSG-6 antibody. This antibody detected the
recombinant mouse TSG-6 at the expected molecular weight ~35 kDa [Fig. 22B].
However, a larger band (~65 kDa) was detected in the apical washes of AECs [Fig. 22B].
No band was detected in the basal medium, which indicates that neither the defined
culture medium nor basally secreted products from the AECs contain reactive bands. The
~60 kDa band was present in the apical washes from WT AECs but absent in the apical
washes of TSG-6 null AECs [Fig. 17B], indicating that the antibody is likely detecting
TSG-6 in a dimerized form. Therefore, AECs can express TSG-6 on both transcriptional
[Fig. 22A] and translational level [Fig. 22B, Fig. 17B].
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Fig. 22. AECs produce TSG-6 Apically that is required for the HC3-HA Complex
Formation. (A) TSG-6 expression of a 10 day murine AECs is shown by the ethidium
bromide stained PCR product of TSG-6 separated on a 1% agarose gel and by
comparison to murine extracts of dermal fibroblast cultures treated with TNFα, using βactin as the housekeeping gene. (B) Western blot of basal medium and apical washes of a
10 day AEC culture were probed with an antibody against TSG-6 that can also detect the
murine recombinant TSG-6 (mrTSG-6) used as a positive control.
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IV.4.3. Basement membrane deposited by MDCK cells contains neither TSG-6 nor
HC3
We also analyzed the basement membrane deposited by MDCK cells that the AECs are
cultured on during their differentiation, by Western blotting for HC3 and TSG-6 protein
levels since MDCK cells are also kidney epithelial cells. Protein levels of HC3 and TSG6 were not detected as shown in [Fig. 23] confirming that the source of these two proteins
is from the AECs and not the basement membrane, and that the proteins found in the
basement membrane are not interfering with the method of detection of the antibodies
used in this study.
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Fig. 23. Basement Membrane Deposited by MDCK Cells does not contain
Detectable Levels of HC3 or TSG-6. (A) Western blot of protein extracts of the
basement membrane synthesized by the MDCK cells on the transwells probed with
antibodies against TSG-6 (lane 2) and HC-3 (lane 3) with recombinant TSG-6 (lane 1) as
a positive control for the TSG-6 antibody used. (B) Gel of protein extracts of the
deposited basement membrane by the MDCK cells stained with Coomassie Blue stain for
protein detection.
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CHAPTER V
CONCLUDING REMARKS

HA can be uniquely modified during inflammation by the transfer of HCs from IαI to
form HC-HA complexes mediated by TSG-6. HC-HA matrices are leukocyte adhesive as
demonstrated in many pathological conditions. Further, TSG-6 has an essential role in
normal biology because the lack of the TSG-6 mediated HC-HA matrix in normal
cumulus cell-oocyte complexes causes female infertility in TSG-6-/- female mice [1].
This demonstrates that HC-HA matrices can be part of a normal extracellular matrix as
well as an inflammatory response to stimuli.
Unlike any other cell type reported so far, AECs uniquely release leukocyte-adhesive
HC3-HA complexes from their apical surface into their extracellular space even in the
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absence of inflammatory stimuli. These HC3-HA rafts were not only observed in the
air/liquid AEC culture model but also in the bronchoalveolar lavage of naïve mice
implying that these rafts are part of murine normal secretions and can have a role as a
host defense mechanism.
Leukocyte adhesion to HA rafts was also observed to a lesser extent in the absence of a
TSG-6 mediated HC transfer suggesting that HC attachment to the HA raft is not the sole
explanation for leukocyte binding. This adhesion could be due to the involvement of
other HA binding proteins that could be further investigated or, similar to HA cables
formed without HC addition, HA rafts could bind leukocytes even in the absence of
binding proteins such as HCs [2].
In this study, we show that murine AECs can synthesize their own heavy chain donor as
pre-IαI complex of HC3 and bikunin, which was previously reported to be constitutively
expressed by human proximal tubular epithelial cells (PTECs) [3]. Furthermore, we also
show that murine AECs constitutively express TSG-6 as do PTECs. However, in this
study the production of HC3-bikunin and TSG-6 by human PTECs was investigated in
the context of their contribution to the pathogenesis of renal fibrosis. At present it is
unclear whether PTECs behave in a similar manner as AECs by forming HA rafts.
Because both cell types have a similar cell lineage, this would be worth investigating in
the future.
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The study by Forteza et al. [4] also provided evidence that normal human epithelial cell
cultures have low levels of mRNA for TSG-6, bikunin and HC3, which were increased
moderately by treatment with TNF-α. This study also showed that epithelia in sections of
trachea from smokers showed increased staining for IαI and bikunin compared with
normal tracheal sections. This provides evidence that human airway epithelia may also
normally make HC3-HA rafts, which are amplified during inflammatory processes such
as smoking and asthma.
Furthermore, we have developed a culture model where AECs are cultured on a
basement membrane deposited by MDCK cells. This basement membrane closely
resembles the one in vivo and results in an airway epithelium that resembles its
counterpart in vivo. The presence of a basement membrane allows primary cells to
polarize and differentiate, in this case, into pseudotratified ciliated epithelial cells. This
unique culture model has the potential to become a widely used tool not only for
culturing AECs but also for other primary cell types such as Human Umbilical Vein
Epithelial Cells (HUVECs).
Airway Epithelium is one of our first lines of defense that provides both a chemical and a
physical barrier. A lot of studies have shown the responsiveness of the AECs to external
pathogenic attack by the release of different cytokines. We have demonstrated that these
cells are also equipped with HA rafts because they can make their HC donor and TSG-6,
and it would be interesting to investigate their contribution during inflammation and their
effect on subjacent cells. We have developed a co-culture system that uses our model of
culturing AECs to investigate the cross-talk between AECs and ASMCs as shown in
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[Fig. 24]. We can also extend our investigation to include AECs from different knock-out
mice for proper dissection of the different pathways involved.
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Fig. 24. A Schematic Illustration of the Use of Co-culture Model in Investigating the
Cross-Talk between AECs and ASMCs.
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In summary, this study provides the first description of leukocyte-adhesive HA rafts
located in the extracellular space on murine AEC apical surfaces. This unique release
mechanism of HA rafts defines the HC-HA complex as a previously unidentified
component of respiratory secretions. Murine HA rafts are identified as HC3-HA
complexes that AECs can make in the absence of inflammatory stimuli. Thus, HA rafts
perhaps serve as a broad anchor for leukocytes at the airway surface ready to be utilized
upon a pathogenic attack or could be an anchor to other proteins and enzymes that might
be involved in a host defense mechanism [6]. Therefore, this study fills important gaps in
our current understanding of murine airway epithelial biology and secretions that relate to
human health and disease.
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APPENDIX A
KDEL
KDEL The abbreviation KDEL is formed by the corresponding letters to each amino
acid, K for Lysine, D for Aspartic acid, E Glutamic acid, L for Leucine.
KDEL is a sequence in the amino acid structure of a protein which keeps it from being
secreted from the endoplasmic reticulum (ER). Proteins can only leave the ER after this
sequence has been cleaved off. It is accumulation in the ER is indicative of an ER stress.
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APPENDIX B
CD44 “ Capping”
The presence of HA cables at sites of tissue inflammation can still function as an antiinflammatory polymer. Monocytes adhere tightly to the HA cables regardless of their
activation state, and following adhesion the dis- tribution of CD44 on the monocyte cell
surface polarizes to form a “cap” while a portion of the HA cable is internalized.

Fig 25. Capping of CD44 on leukocytes. (A) Monocytes bind to HA cables (green)
produced by SMC in response to poly I:C. CD44 (red) is dispersed on the monocyte
surface. (B) After 15 min incubation at 37°C, CD44 (red) is capped to one pole on the
leukocytes, HA cables appear ragged (center panel) and HA is internalized. (Nuclei are
blue).
[Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in
inflammation? Trends Immunol. 2005; 26(12):637–43].
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